Psychedelics and Neuroplasticity: How Reopened Critical Periods May Support Emotional Healing and Personal Growth

Psychedelics may support emotional healing by reopening brain states associated with heightened neuroplasticity, according to a Nature study led by Romain Nardou and Gül Dölen. In mice, LSD, psilocybin, and MDMA reopened a critical period for social reward learning, allowing isolated animals to regain positive responses to social interaction. The duration of this window appeared to track the drugs' subjective effects, lasting weeks after LSD and for a shorter period after MDMA, with possible roles for oxytocin pathways and the extracellular matrix. The findings may help explain research and reports involving trauma, anxiety, addiction, and relationship change, but they are not proof of equivalent human outcomes. Plasticity is neutral and can reinforce harmful patterns without appropriate preparation, supportive context, and integration. The piece also notes psychosis risks, access barriers, and the value of harm reduction and integration support.